| Literature DB >> 27075624 |
Pedro Romero1, Jacques Banchereau2, Nina Bhardwaj3, Mark Cockett4, Mary L Disis5, Glenn Dranoff6, Eli Gilboa7, Scott A Hammond8, Robert Hershberg9, Alan J Korman10, Pia Kvistborg11, Cornelis Melief12, Ira Mellman13, A Karolina Palucka14, Irina Redchenko15, Harlan Robins16, Federica Sallusto17, Theodore Schenkelberg18, Stephen Schoenberger19, Jeffrey Sosman20, Özlem Türeci21, Benoît Van den Eynde22, Wayne Koff23, George Coukos24.
Abstract
Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited by most vaccines tested, but their clinical efficacy remains modest. We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27075624 DOI： 10.1126/scitranslmed.aaf0685
Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956